JPS62151759A - Detection of antigen material - Google Patents

Detection of antigen material

Info

Publication number
JPS62151759A
JPS62151759A JP29488785A JP29488785A JPS62151759A JP S62151759 A JPS62151759 A JP S62151759A JP 29488785 A JP29488785 A JP 29488785A JP 29488785 A JP29488785 A JP 29488785A JP S62151759 A JPS62151759 A JP S62151759A
Authority
JP
Japan
Prior art keywords
cells
glass
antigenic substance
protein
antigenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP29488785A
Other languages
Japanese (ja)
Inventor
Shogo Masuda
益田 昭吾
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Minaris Medical Co Ltd
Original Assignee
Kyowa Medex Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Medex Co Ltd filed Critical Kyowa Medex Co Ltd
Priority to JP29488785A priority Critical patent/JPS62151759A/en
Publication of JPS62151759A publication Critical patent/JPS62151759A/en
Pending legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

PURPOSE:To make easy detection, concentration, sepn. and refining of an antigenic material by using the solubilized protein A which is fixed to a carrier consisting of slide glass or the like and is bound with an antibody for a specific antigenic material. CONSTITUTION:The antigenic material is bound with the carrier made of glass, plastic or paper via the antibody for the antigenic material and the protein A and the antigenic material is qualitatively or quantitatively analyzed, by which the antigenic material is detected. The protein A-carrier conjugate is cultured in a medium as necessary to propagate the antigenic material and the bound or propagated antigenic material is recovered, by which the antigenic material is concd., separated or refined. The carrier of a plane or bar shape is used; for example, slide glass, glass bar, etc., are used. The protein A may be used alone or in the form of the cells bonding with the cells to produce. The eucaryotic cells, procaryotic cells and virus are used for the antigenic material and a polyclonal antibody and monoclonal antibody are used for the antibody for the antigenic material.

Description

【発明の詳細な説明】 産業上の利用分野 本発明は、ガラス製、プラスチック製または紙製の担体
とプロティンAとの結合物を利用して抗原性物質を分析
、濃縮1分離ならびに精製する方法を提供する。従って
、本発明は臨床検査医学の領域にとどまらず広く医学5
生物学の分野において利用できる。
DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application The present invention relates to a method for analyzing, concentrating, separating, and purifying antigenic substances using a conjugate of protein A and a carrier made of glass, plastic, or paper. I will provide a. Therefore, the present invention is applicable not only to the field of clinical laboratory medicine but also to a wide range of medical fields.
Can be used in the field of biology.

従来技術 プロティンAを利用してIgGを含む細胞表面抗原の検
出1分離などが行われている〔イムノロシイ(Immu
nol、)、  26.1081−1(15)1.19
74.  スカンジナビアン・ジャーナル・オブ・イム
ノロシイ(Scand、J、Immunol、)、 3
.405−411. 1974] 。
Conventional technology Protein A has been used to detect and separate cell surface antigens including IgG [Immunology
nol, ), 26.1081-1(15)1.19
74. Scandinavian Journal of Immunology (Scand, J. Immunol), 3
.. 405-411. 1974].

またプロティンAで被覆した赤血球を用いたロゼツト形
成反応による表面抗原の検出〔プロシイ−ディング・オ
ブ・ザ・ナショナル・アカデミイ・オブ・サイエンス(
Proc、Natl、Acad、  Sci、)、  
USA  71゜4831−4835. 1974 )
 、  フルオレセインイソチオシアネー)(FITC
)で標識したプロティンΔを用いる組織内特異抗原の検
出、プロティンAを固定化したプロティンA−セファロ
ースを用いたTgG抗体の精製〔エフ・イー・ビー・ニ
ス・レターズ(FεOS Letters、)、 28
.73−76、1972 〕などにプロティンAは広く
用いられている。
In addition, detection of surface antigens by rosette formation reaction using red blood cells coated with protein A [Procedures of the National Academy of Sciences (
Proc, Natl, Acad, Sci,),
USA 71°4831-4835. 1974)
, Fluorescein Isothiocyanate) (FITC
) Detection of tissue-specific antigen using protein Δ labeled with protein Δ, purification of TgG antibody using protein A-Sepharose immobilized with protein A [FεOS Letters, 28
.. 73-76, 1972], protein A is widely used.

臨床試薬としては肺炎球菌、その他の細菌の血清学的診
断法であるコアグルチネーション法〔ジャーナル・オブ
・メディカル・ミクロバイオロジ4   (J9Med
、Microbiol、)、    16.  187
−190.  1973   )が知られている。プロ
ティンAを結合したセファロース6MBCジャーナル・
オブ・イムノロジカル・メソッズ(J、Immunol
lMeth、)、 24.305−3(15)゜197
8)や磁気性微粒子を用いた細胞の分離法は知られてい
る。
As a clinical reagent, the coagglutination method, which is a serological diagnostic method for pneumococci and other bacteria [Journal of Medical Microbiology 4 (J9Med
, Microbiol, ), 16. 187
-190. 1973) is known. Sepharose 6MBC journal with protein A binding
of Immunological Methods (J, Immunol
lMeth,), 24.305-3(15)゜197
8) and cell separation methods using magnetic particles are known.

しかしながら平面状あるいは棒状のガラス製。However, it is made of flat or rod-shaped glass.

紙製あるいはプラスチック製担体を用いてプロティンA
を固定化したものを用いて抗原性物質を検出、a縮1分
離ならびに精製する方法については知られていない。
Protein A using paper or plastic carriers
There is no known method for detecting, isolating, and purifying antigenic substances using immobilized A.

発明の解決課題および解決手段 従来、抗原性物質とくに微生物を臨床検査上同定するに
は微生物を含む検査材料の一部を選択培地上に塗抹培養
し目的とする菌を増殖させたのち生物学的諸性状を分析
し血清学的診断法を用いて同定する方法が行われてきた
。この場合微生物により固有の培地を用いなければなら
ず、圧倒的に多数を占める混在雑菌の中から目的とする
細菌を分離するのは手間と時間がかかり判定も煩わしい
ので簡便で確実な方法が望まれていた。
Problems to be Solved by the Invention and Means for Solving Conventionally, in order to identify antigenic substances, especially microorganisms, in clinical tests, a part of the test material containing the microorganisms is smeared and cultured on a selective medium to grow the target bacteria, and then biological Identification methods have been carried out by analyzing various properties and using serological diagnostic methods. In this case, it is necessary to use a unique culture medium depending on the microorganism, and separating the target bacteria from the overwhelming majority of mixed bacteria takes time and effort, and the determination is also troublesome, so a simple and reliable method is desired. It was rare.

また動物細胞を取り扱う場合目的とする細胞だけを培養
基上に選択的に増殖できれば材料の節約はもとより手間
も時間も節約できると考えられる。
Furthermore, when handling animal cells, if only the desired cells can be selectively grown on a culture medium, it is thought that not only materials but also labor and time can be saved.

本発明者は、可溶化プロティンAをスライドグラスなど
の担体に固定化し、特定の抗原性物質に対する抗体を結
合させたものを用いれば、該抗原性物質の検出、a縮1
分離ならびに精製が簡便に効率よくできることを見出し
本発明を完成した。
The present inventors believe that if solubilized protein A is immobilized on a carrier such as a slide glass and an antibody against a specific antigenic substance is used, the detection of the antigenic substance can be carried out.
The present invention was completed by discovering that separation and purification can be carried out simply and efficiently.

発明の構成 本発明は、抗原性物質を該抗原性物質に対する抗体およ
びプロティンAを介してガラス製、プラスチック製また
は紙製の担体に結合させ、該抗原性物質を定性的または
定量的に分析することにより抗原性物質を検出する方法
および抗原性物質を該抗原性物質に対する抗体およびプ
ロティンΔを介してガラス製、プラスチック製または紙
製の担体に結合させ、必要に応じ培地に培養して抗原性
物質を増殖させ、結合したまたは増殖した抗原性物質を
回収することにより抗原性物質を濃縮9分離または精製
する方法ならびにプロティンAをガラス製、プラスチッ
ク製または紙製の担体に結合させた、抗原性物質の検出
、濃縮1分離または精製用、プロティンA−担体結合物
を提供する。
Structure of the Invention The present invention involves binding an antigenic substance to a carrier made of glass, plastic, or paper via an antibody against the antigenic substance and protein A, and qualitatively or quantitatively analyzing the antigenic substance. A method for detecting an antigenic substance by binding the antigenic substance to a carrier made of glass, plastic, or paper via an antibody against the antigenic substance and protein Δ, and culturing it in a medium as necessary to detect antigenicity. A method for concentrating or purifying antigenic substances by propagating the substance and recovering the bound or proliferated antigenic substances, as well as methods for the isolation or purification of antigenic substances by binding Protein A to glass, plastic or paper carriers. Provided is a protein A-carrier conjugate for the detection, concentration, separation or purification of substances.

担体としては、平面状または棒状のガラス製、プラスチ
ック製または紙製のものが用いられる。
As the carrier, a flat or rod-shaped carrier made of glass, plastic, or paper is used.

ガラス製、プラスチック製の担体としては、スライドグ
ラス、ガラス棒、シャーレ、フラスコ、ロートなどが用
いられる。担体の大きさは処理する試料の量、使用目的
に応じて適宜法める。
As the glass or plastic carrier, a slide glass, a glass rod, a petri dish, a flask, a funnel, etc. are used. The size of the carrier is determined as appropriate depending on the amount of sample to be processed and the purpose of use.

本発明の方法は、一般にガラス製、プラスチック製また
は紙製の担体にプロティンAを固定化させ、このプロテ
ィンAに抗原性物質に対する抗体を結合させたものに抗
原性物質を結合させ、結合した抗原性物質を定性的また
は定量的に分析することにより抗原性物質を検出するこ
とができる。
In the method of the present invention, protein A is generally immobilized on a carrier made of glass, plastic, or paper, and the antigenic substance is bound to the protein A to which an antibody against the antigenic substance is bound. Antigenic substances can be detected by qualitatively or quantitatively analyzing the antigenic substances.

また抗原性物質を結合したものを必要に応じ培地に培養
して抗原性物質を増殖させ、結合したまたは増殖した抗
原性物質を回収することにより抗原性物質を濃縮1分離
および精製を行うことができる。担体、プロティンA、
抗体および抗原性物質の結合は、上記の手順で行うのが
通常であるが、順序を変えて行うこともできる。
In addition, it is possible to concentrate, separate, and purify the antigenic substance by culturing the bound antigenic substance in a medium as necessary to multiply the antigenic substance, and then collecting the bound or proliferated antigenic substance. can. carrier, protein A,
The binding of antibodies and antigenic substances is usually carried out according to the above procedure, but it can also be carried out in a different order.

プロティンAとしては、スタフィ、ロコッカス・アウレ
ウス(Staphylococcus aureus)
 (ジャーナル・オブ・イム10シイ(J、Immun
ol、) 103 : 828−833.1969)に
より生産されるもの、組換えDNA手法〔ジャーナル・
オプ・バクテリオロジイ(J。
As protein A, Staphy, Staphylococcus aureus
(Journal of Immun
ol, ) 103: 828-833.1969), recombinant DNA techniques [Journal.
Op Bacteriology (J.

Bacteriol、159 : 713.1984)
により生産されるものが用いられる。ファルマシア・フ
ァイン・ケミカル社製の市販のプロティンAを用いるこ
ともできる。プロティンAは単品として、また生産す:
         る細菌に細胞結合性の形で用いるこ
ともできる。
Bacteriol, 159: 713.1984)
The one produced by is used. Commercially available Protein A manufactured by Pharmacia Fine Chemicals may also be used. Protein A can also be produced as a single product:
It can also be used in cell-bound form for bacteria.

たとえば、黄色ブドウ球菌Cowan I株はプロティ
ンA含を菌株として知られており、これからプロティン
八を単離せずに用いることもできる。
For example, Staphylococcus aureus Cowan I strain is known as a protein A-containing strain, and can be used without isolating protein A from this strain.

ジャーナル・オブ・イムノロシイ(J、 Immu口O
1,)135、2589. 1985 に記載されたプ
ロティンGはプロティンAと同様の活性をもつ蛋白質で
あるので、プロティンΔに替えてプロティンGを用いる
こともできる。
Journal of Immunology
1,) 135, 2589. Protein G, which was described in 1985, is a protein that has the same activity as protein A, so protein G can be used in place of protein Δ.

抗原性物質としては、真核細胞、原核細胞、ウィルスな
どが対象となる。真核細胞は動、植物の細胞たとえばヒ
ツジ赤血球、ヒト白血球、エールリッヒ癌細胞、キャン
ディダ・アルビカンスなどの酵母が、原核細胞は腸チフ
ス菌、ネズミチフス菌、腸炎ビブリオ、大腸菌、志賀赤
痢菌などの細菌、リケッチア、クラミヂア、放線菌、カ
ビなどがあげられる。
Antigenic substances include eukaryotic cells, prokaryotic cells, and viruses. Eukaryotic cells include animal and plant cells, such as sheep red blood cells, human white blood cells, Ehrlich cancer cells, and yeast such as Candida albicans; prokaryotic cells include bacteria such as Salmonella typhi, Salmonella typhimurium, Vibrio parahaemolyticus, Escherichia coli, and Shigella shigella; Examples include rickettsia, chlamydia, actinomycetes, and molds.

抗原性物質に対する抗体としては、ポリクローナル抗体
またはモノクローナル抗体が用いられる。
As antibodies against antigenic substances, polyclonal antibodies or monoclonal antibodies are used.

ポリクローナル抗体は、抗原性物質をイヌ、ギネアピッ
グ、ウサギなどに投与して得られる抗血清が、モノクロ
ーナル抗体としては、抗原性物質を用いK15hler
 & Milsteinの方法[:Nature、 2
56゜495−497.1975 )に従って製造した
ものを用いることができる。
Polyclonal antibodies are obtained by administering an antigenic substance to dogs, Guinea pigs, rabbits, etc., and antiserum is obtained.
&Milstein's method [: Nature, 2
56°495-497.1975) can be used.

担体へのプロティンAの固定化方法は、ポI717ジン
ーグルタールアルデヒド法(可溶化プロティンA)、卵
白アルブミン−ゲルタールアルデヒド法(黄色ブドウ球
菌菌体)などが用いられる。これらの方法は、下記文献
に記載の方法に従って行うことができる。
As a method for immobilizing protein A onto the carrier, the po I717 zinc-glutaraldehyde method (solubilized protein A), the ovalbumin-geltaraldehyde method (Staphylococcus aureus cells), etc. are used. These methods can be performed according to the methods described in the following documents.

Biochem、Biophys、Res、Commu
n、 36. 235−242. 1969Arch、
Biochem、Biophys、 129.221−
227. 1969Biochem、Biophys、
Res、Commun、  45. 1574−158
0. 1971εxperImentia  29. 
958−959. 1973Proc、Natl、Ac
ad、Sci]SA、  70. 2534−2538
. 1973プロティンΔ固定担体への抗体の結合は、
抗体を含む液に、プロティンA固定担体を浸し、室温で
10〜60分間放置することによって行う。抗体の結合
した担体を生理的食塩水で洗い、抗原性物質を含む液に
浸し、室温で10〜60分間放置する。抗原性物質の結
合した担体を生理的食塩水で洗い、抗原性物質の検定を
行う。抗原性物質の検定方法は、抗原性物質個有の定性
的または定量的分析方法に従えばよい。抗原性物質が細
菌の場合はダラム染色方法などによる。
Biochem, Biophys, Res, Commu
n, 36. 235-242. 1969 Arch,
Biochem, Biophys, 129.221-
227. 1969Biochem, Biophys,
Res, Commun, 45. 1574-158
0. 1971εxperImentia 29.
958-959. 1973Proc, Natl, Ac
ad, Sci] SA, 70. 2534-2538
.. Binding of the antibody to the 1973 protein Δ immobilized carrier was
This is carried out by immersing the protein A-immobilized carrier in a solution containing the antibody and leaving it at room temperature for 10 to 60 minutes. The antibody-bound carrier is washed with physiological saline, immersed in a solution containing the antigenic substance, and left at room temperature for 10 to 60 minutes. The carrier bound to the antigenic substance is washed with physiological saline, and the antigenic substance is assayed. The method for assaying an antigenic substance may be according to a qualitative or quantitative analysis method specific to the antigenic substance. If the antigenic substance is bacteria, use Durham staining method, etc.

抗原性物質を濃縮1分離、精製する方法において、担体
、抗原性物質、プロティンΔなどは上記抗原性物質の検
出方法と同様で、抗原性物質の結合までの工程も同様に
行う。結合した抗原性物質が細菌細胞、勅、植物細胞な
どの場合は、必要に応じこの結合物を培地に培養するこ
とにより細胞を増殖させ、その後結合した抗原性物質ま
たは増殖した抗原性物質を回収する。かくして抗原性物
質を効率よく簡便にa縮1分離、精製を行うことができ
る。
In the method for concentrating, separating, and purifying an antigenic substance, the carrier, antigenic substance, protein Δ, etc. are the same as in the above method for detecting an antigenic substance, and the steps up to the binding of the antigenic substance are also carried out in the same manner. If the bound antigenic substance is a bacterial cell, cellulose, plant cell, etc., the bound antigenic substance or the grown antigenic substance is recovered by culturing the bound substance in a medium to proliferate the cells, if necessary. do. In this way, antigenic substances can be efficiently and easily separated and purified.

゛以下、本発明の実施例を示す。゛Examples of the present invention will be shown below.

実施例1゜ 直径311110のガラス棒の一端を火焔によって丸く
した。一方、卵白を水で1.(16)0倍に稀釈した液
中に黄色ブドウ球菌Cowan 1株lID975(東
京大学医科学研究所)を5 X 1(15)/mlの農
林濃度で懸濁した。この懸濁液に上記ガラス棒を浸し、
直ちに引き上げてドライヤーで冷風乾燥させた。
Example 1 One end of a glass rod with a diameter of 311,110° was rounded by flame. Meanwhile, add egg whites to 1. (16) Staphylococcus aureus Cowan 1 strain ID975 (The Institute of Medical Science, The University of Tokyo) was suspended in a solution diluted 0 times at a concentration of 5 x 1 (15)/ml. Dip the glass rod into this suspension,
I immediately pulled it out and dried it with cold air using a hair dryer.

このガラス棒を2.5%のゲルタールアルデヒド溶液(
0,2Mリン酸バッファー(pH7,4):lに37℃
で1時間浸した後、生理的食塩水で洗浄した。このガラ
ス棒を、ネズミチフス菌に対するウサギ抗体(凝集素価
2(16)0の抗血清を10倍に希釈したもの)を含む
液に37℃で15分間浸して該抗体を結合させた。該抗
体の製造は次のとおり行った。
This glass rod was mixed with a 2.5% gel taraldehyde solution (
0,2M phosphate buffer (pH 7,4): l at 37°C
After soaking in water for 1 hour, it was washed with physiological saline. The glass rod was immersed in a solution containing a rabbit antibody against Salmonella Typhimurium (a 10-fold dilution of an antiserum with an agglutination titer of 2(16)0) at 37° C. for 15 minutes to bind the antibody. The antibody was produced as follows.

S型のネズミチフス菌をハートインフュージョン寒天平
板(DIFCOLABORATORIBS DIETR
OITMICHIGAN USA ′社製、ウン心臓浸
出液5(16)g/ρ。
Salmonella typhimurium type S was collected on a heart infusion agar plate (DIFCOLABORATORIBS DIETR).
Manufactured by OITMICHIGAN USA', Un heart effusion 5 (16) g/ρ.

トリプトース10g/β、塩化ナトリウム5g、#!。Tryptose 10g/β, sodium chloride 5g, #! .

寒天15g#りで37℃、15時間培養し生理的食塩水
中ニ懸濁(5x l Q9cfu/ml) L、、1(
16)℃で2時間加熱した。生菌に換算してlQ’cf
υ/n+1になるように生理食塩水で稀釈し、これを免
疫原として用いた。この免疫原をウサギ(株式会社日生
材、雌1体重2kg)に1週間間隔で5回静脈内注射し
た。注射量は、第1回Q、5ml、第2回1、Qml、
第3回2.Qml、第4回3.3+nl、第5回3、Q
mlであった。第5回注射後1週間目に試験採血を行い
O抗体価が1.(16)0以上のものを全採血した。こ
れを抗体として用いた。
Culture 15 g of agar at 37°C for 15 hours and suspend in physiological saline (5 x 1 Q9cfu/ml) L, 1 (
16) Heated at ℃ for 2 hours. lQ'cf in terms of viable bacteria
It was diluted with physiological saline to a ratio of υ/n+1 and used as an immunogen. This immunogen was intravenously injected into rabbits (manufactured by Nichizai Co., Ltd., female weighing 2 kg) five times at weekly intervals. The injection amount was 1st Q, 5ml, 2nd injection 1, Qml,
3rd 2. Qml, 4th 3.3+nl, 5th 3, Q
It was ml. Test blood was drawn one week after the fifth injection, and the O antibody titer was 1. (16) Whole blood was collected from those with 0 or more. This was used as an antibody.

抗体結合ガラス棒を、ネズミチフス菌105個/mlお
よび大腸菌108個/mlを含む菌浮遊液中に25℃で
5分間浸した後、l Qmlの生理的食塩水で3回洗っ
た。このガラス棒をBTB平板培地に塗抹し、37℃で
一晩培養したところネズミチフス菌および大腸菌のコロ
ニーはそれぞれ40個および4個であった。はじめの菌
浮遊液のなかにおけるネズミチフス菌と大腸菌の比は1
:1(16)0、最後の段階でBTB平板上に於ける比
は10:1なのでネズミチフス菌は大腸菌にくらべてi
o、oo。
The antibody-conjugated glass rods were immersed in a bacterial suspension containing 105 Salmonella typhimurium/ml and 108 E. coli/ml for 5 minutes at 25°C, and then washed three times with 1 Qml of physiological saline. When this glass rod was smeared onto a BTB plate medium and cultured overnight at 37°C, the number of Salmonella typhimurium and Escherichia coli colonies was 40 and 4, respectively. The ratio of Salmonella typhimurium to E. coli in the initial bacterial suspension is 1.
:1(16)0, the ratio on the BTB plate at the final stage is 10:1, so Salmonella typhimurium is i
o, oo.

倍濃縮されたといえる。It can be said to be twice as concentrated.

モノクローナル抗体をに6hler and Mils
teinの方法に準じて上述のネズミチフス菌免疫原を
用いて作りこれと平行的にマウス免疫グロブリンでウサ
ギを免疫して得た抗血清を前述の黄色ブドウ球菌菌体結
合ガラス棒にまず結合させ、生理的食塩水でよ(洗った
後抗ネズミチフス菌モノクローナル抗体を棒に結合させ
再び生理的食塩水でよく洗った。このガラス棒を前述の
ものと同じネズミチフス菌大腸菌混合浮遊液中に25℃
で5分間浸し生理的食塩水で洗ってBTB寒天平板に塗
抹培養したところネズミチフス菌および大腸菌のコロニ
ーはそれぞれ124個、3個であった。
6hler and Mils monoclonal antibodies
An antiserum prepared using the Salmonella Typhimurium immunogen described above according to the method of Tein and obtained by immunizing a rabbit with mouse immunoglobulin in parallel was first bound to the glass rod bound to the Staphylococcus aureus cells described above. After washing with physiological saline, an anti-Salmonella typhimurium monoclonal antibody was bound to the rod and the rod was thoroughly washed again with physiological saline.The glass rod was placed in the same suspension of Salmonella typhimurium E. coli as mentioned above at 25°C.
When the cells were soaked in water for 5 minutes, washed with physiological saline, and plated on a BTB agar plate, the number of Salmonella typhimurium and Escherichia coli colonies was 124 and 3, respectively.

実施例2゜ スライドグラスにポリーL−リジン ハイドロプロミド
(Sigma製、  No、 1524 )をImg/
mlの割合で脱イオン水に溶解し10μβをスライドグ
ラス上に塗抹標本作製の要領で塗布した。ただちに冷風
で乾燥後湿潤箱に納め、2.5%ゲルタールアルデヒド
液(0,2Mリン酸バッファーp H7,4)を重層し
、37℃で1時間放置し、0.2 M !Iン酸バッフ
ァ (pH7,4)で洗い、コレl:5(16)xr/
mlのプロティンA溶液5(16)μlを重層し、37
℃で1時間放置し、生理的食塩水で洗った。
Example 2 Poly L-lysine hydropromide (manufactured by Sigma, No. 1524) was added to a slide glass.
ml of the solution was dissolved in deionized water and 10 μβ was applied onto a slide glass in the same manner as for preparing a smear. Immediately dry it with cold air, put it in a humidity box, layer it with 2.5% geltaraldehyde solution (0.2M phosphate buffer pH 7.4), leave it at 37°C for 1 hour, and add 0.2M! Wash with I phosphate buffer (pH 7,4), and remove
Overlay 5 (16) μl of protein A solution and
It was left at ℃ for 1 hour and washed with physiological saline.

上記スライドグラスに生理的食塩水で10倍に希釈した
抗ヒツジ赤血球ウサギ抗血清1mlを重層し37℃15
分間放置後生理的食塩水で洗った。
1 ml of anti-sheep red blood cell rabbit antiserum diluted 10 times with physiological saline was overlaid on the above slide glass at 37°C.
After leaving it for a minute, it was washed with physiological saline.

これに対する陰性対照としてヒツジ赤血球に替えて、正
常ウサギ血清を用いて同様にスライドグラスに結合させ
た。
As a negative control for this, normal rabbit serum was used instead of sheep red blood cells and bound to the slide glass in the same manner.

両スライドグラスに2 X 105/mlのヒツジ赤血
球浮遊液1mlを重層し、25℃で15分間放置した。
Both slide glasses were overlaid with 1 ml of a 2×10 5 /ml sheep red blood cell suspension and left at 25° C. for 15 minutes.

このスライドグラスを反応面を下にして生理的食塩水中
に45°の角度を持たせて浸した。
The glass slide was immersed in physiological saline at a 45° angle with the reaction side facing down.

15分後にスライドグラスを取り出し、カバーグラスを
被せ顕微鏡で観察した。4(16)倍の視野中の赤血球
の数を計測したところ特異抗体結合面では4.(16)
0個、対照面では20個の赤血球が検出された。
After 15 minutes, the slide glass was taken out, covered with a cover glass, and observed under a microscope. When the number of red blood cells was counted in a 4 (16) magnification field of view, the number of red blood cells was 4. (16)
0 red blood cells were detected, and 20 red blood cells were detected on the control side.

実施例3゜ 実施例2と同じ方法でスライドグラスの代わりに細胞培
養用プラスチックシャーレ(Φ5.3 mm 。
Example 3 The same method as in Example 2 was used, except for using a plastic petri dish for cell culture (Φ5.3 mm) instead of the slide glass.

■テルモ製)にプロティンAを固定化し、このシャーレ
にインスリン分泌細胞の膜抗原に対する抗体を大量に含
有している若年性糖尿病患者の血清をリン酸緩衝化生理
的食塩水で10倍あるいは1(16)倍に希釈したもの
を重層し、余分の液を捨てた後湿潤筒中で37℃5分間
反応させた後上述のリン酸緩衝化生理的食塩水で洗い、
5 X 105個/mlのJHPI−1(ヒト膵ランゲ
ルハンス島由来のインスリン分泌性細胞株) (Jik
eikai !Jed。
■ Protein A is immobilized on a plate (manufactured by Terumo), and in this petri dish, serum from a juvenile diabetic patient containing a large amount of antibodies against the membrane antigen of insulin-secreting cells is diluted with phosphate-buffered physiological saline 10x or 1x ( 16) Layer the two-fold diluted mixture, discard the excess liquid, react in a humid cylinder at 37°C for 5 minutes, and then wash with the above-mentioned phosphate buffered physiological saline.
5 x 105 cells/ml JHPI-1 (insulin-secreting cell line derived from human pancreatic islets of Langerhans) (Jik
Eikai! Jed.

J、  28.257−265.1981. Arch
、 1ist、 Jap、45゜111−119.19
82)を重層し、第1表のごとき条件で静置した。一定
時間後このシャーレをリン酸緩衝化生理的食塩水で洗っ
てシャーレ底に粘着している細胞をスケールがついてい
るガラスを重ねることにより計測した。これらの結果か
らみると若年性糖尿病患者血清を作用させたシャーレに
は正常人血清を作用させたシャーレの約50〜1(16
)倍の密度で細胞が粘着することが確認された。
J, 28.257-265.1981. Arch
, 1ist, Jap, 45°111-119.19
82) was layered and allowed to stand under the conditions shown in Table 1. After a certain period of time, the petri dish was washed with phosphate-buffered physiological saline, and the cells adhering to the bottom of the dish were counted by placing a glass plate with a scale on top. Judging from these results, the petri dish treated with serum from a juvenile diabetic patient is about 50 to 1 (16
) It was confirmed that cells adhered at twice the density.

第    1    表 3 〃2520410415 4 〃2530402417 5 〃2560419408 6 〃375531484 7 〃3710693645 8  正常成人  37   10    7   4
(対照) 本発明によれば、抗原性物質を効率よく簡便に検出、a
縮1分離、精製することができる。
Table 1 3 〃2520410415 4 〃2530402417 5 〃2560419408 6 〃375531484 7 〃3710693645 8 Normal adult 37 10 7 4
(Control) According to the present invention, antigenic substances can be efficiently and easily detected, a
It can be separated and purified by condensation.

Claims (17)

【特許請求の範囲】[Claims] (1)抗原性物質を該抗原性物質に対する抗体およびプ
ロテインAを介してガラス製、プラスチック製または紙
製の担体に結合させ、該抗原性物質を定性的または定量
的に分析することにより抗原性物質を検出する方法。
(1) Antigenicity is determined by binding an antigenic substance to a carrier made of glass, plastic, or paper via an antibody against the antigenic substance and protein A, and analyzing the antigenic substance qualitatively or quantitatively. How to detect substances.
(2)担体がスライドグラス、ガラス棒、シャーレ、フ
ラスコおよびロートから選ばれる特許請求の範囲第1項
の方法。
(2) The method according to claim 1, wherein the carrier is selected from a glass slide, a glass rod, a petri dish, a flask, and a funnel.
(3)抗原性物質が真核細胞、原核細胞およびウィルス
から選ばれる特許請求の範囲第1項の方法。
(3) The method according to claim 1, wherein the antigenic substance is selected from eukaryotic cells, prokaryotic cells, and viruses.
(4)真核細胞がヒツジ赤血球、ヒト白血球およびエー
ルリッヒ癌細胞から選ばれる特許請求の範囲第3項の方
法。
(4) The method of claim 3, wherein the eukaryotic cells are selected from sheep red blood cells, human white blood cells, and Ehrlich cancer cells.
(5)原核細胞が腸チフス菌、ネズミチフス菌、腸炎ビ
ブリオ、大腸菌および志賀赤痢菌から選ばれる特許請求
の範囲第3項の方法。
(5) The method of claim 3, wherein the prokaryotic cell is selected from Salmonella typhi, Salmonella typhimurium, Vibrio parahaemolyticus, Escherichia coli, and Shigella shigella.
(6)抗体が抗原性物質に反応性を有するポリクローナ
ル抗体またはモノクローナル抗体である特許請求の範囲
第1項の方法。
(6) The method according to claim 1, wherein the antibody is a polyclonal antibody or a monoclonal antibody having reactivity with an antigenic substance.
(7)抗原性物質を該抗原性物質に対する抗体およびプ
ロテインAを介してガラス製、プラスチック製または紙
製の担体に結合させ、必要に応じ培地に培養して抗原性
物質を増殖させ、結合したまたは増殖した抗原性物質を
回収することにより抗原性物質を濃縮、分離または精製
する方法。
(7) The antigenic substance was bound to a glass, plastic, or paper carrier via an antibody against the antigenic substance and protein A, and if necessary, cultured in a medium to proliferate and bind the antigenic substance. Or a method of concentrating, separating or purifying antigenic substances by collecting the proliferated antigenic substances.
(8)担体がスライドグラス、ガラス棒、シャーレ、フ
ラスコおよびロートから選ばれる特許請求の範囲第7項
の方法。
(8) The method according to claim 7, wherein the carrier is selected from a slide glass, a glass rod, a petri dish, a flask, and a funnel.
(9)抗原性物質が真核細胞、原核細胞およびウィルス
から選ばれる特許請求の範囲第7項の方法。
(9) The method according to claim 7, wherein the antigenic substance is selected from eukaryotic cells, prokaryotic cells, and viruses.
(10)真核細胞がヒツジ赤血球、ヒト白血球およびエ
ールリッヒ癌細胞から選ばれる特許請求の範囲第9項の
方法。
(10) The method of claim 9, wherein the eukaryotic cells are selected from sheep red blood cells, human white blood cells, and Ehrlich cancer cells.
(11)原核細胞が腸チフス菌、ネズミチフス菌、腸炎
ビブリオ、大腸菌および志賀赤痢菌から選ばれる特許請
求の範囲第9項の方法。
(11) The method of claim 9, wherein the prokaryotic cell is selected from Salmonella enterica, Salmonella typhimurium, Vibrio parahaemolyticus, Escherichia coli, and Shigella shigella.
(12)抗体が抗原性物質に反応性を有するポリクロー
ナル抗体またはモノクローナル抗体である特許請求の範
囲第7項の方法。
(12) The method according to claim 7, wherein the antibody is a polyclonal antibody or a monoclonal antibody having reactivity with an antigenic substance.
(13)プロテインAをガラス製、プラスチック製また
は紙製の担体に結合させた、抗原性物質の検出、濃縮、
分離または精製用、プロテインA−担体結合物。
(13) Detection and concentration of antigenic substances by binding protein A to glass, plastic or paper carriers;
Protein A-carrier conjugate for separation or purification.
(14)担体がスライドグラス、ガラス棒、シャーレ、
フラスコおよびロートから選ばれる特許請求の範囲第1
3項の結合物。
(14) The carrier is a slide glass, a glass rod, a petri dish,
Claim 1 selected from flask and funnel
A combination of three terms.
(15)抗原性物質が真核細胞、原核細胞およびウィル
スから選ばれる特許請求の範囲第13項の結合物
(15) The conjugate according to claim 13, wherein the antigenic substance is selected from eukaryotic cells, prokaryotic cells, and viruses.
(16)真核細胞がヒツジ赤血球、ヒト白血球およびエ
ールリッヒ癌細胞から選ばれる特許請求の範囲第15項
の結合物。
(16) The conjugate according to claim 15, wherein the eukaryotic cells are selected from sheep red blood cells, human white blood cells, and Ehrlich cancer cells.
(17)原核細胞が腸チフス菌、ネズミチフス菌、腸炎
ビブリオ、大腸菌および志賀赤痢菌から選ばれる特許請
求の範囲第15項の結合物。
(17) The conjugate according to claim 15, wherein the prokaryotic cell is selected from Salmonella typhimurium, Salmonella typhimurium, Vibrio parahaemolyticus, Escherichia coli, and Shigella shigella.
JP29488785A 1985-12-26 1985-12-26 Detection of antigen material Pending JPS62151759A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP29488785A JPS62151759A (en) 1985-12-26 1985-12-26 Detection of antigen material

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29488785A JPS62151759A (en) 1985-12-26 1985-12-26 Detection of antigen material

Publications (1)

Publication Number Publication Date
JPS62151759A true JPS62151759A (en) 1987-07-06

Family

ID=17813534

Family Applications (1)

Application Number Title Priority Date Filing Date
JP29488785A Pending JPS62151759A (en) 1985-12-26 1985-12-26 Detection of antigen material

Country Status (1)

Country Link
JP (1) JPS62151759A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59139936A (en) * 1983-02-01 1984-08-11 Terumo Corp Immunoglobulin g adsorbent
JPS59197862A (en) * 1983-04-26 1984-11-09 Eiken Kagaku Kk Reagent for immunoassay to measure simultaneously multiple terms

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59139936A (en) * 1983-02-01 1984-08-11 Terumo Corp Immunoglobulin g adsorbent
JPS59197862A (en) * 1983-04-26 1984-11-09 Eiken Kagaku Kk Reagent for immunoassay to measure simultaneously multiple terms

Similar Documents

Publication Publication Date Title
CA1213536A (en) Monoclonal antibody, method of producing the same and use thereof
JP2986961B2 (en) How to detect the presence of microorganisms
JPS62501233A (en) Products for separation applicable to cells in immunopurification
JP5777877B2 (en) Method and kit for immunological detection of bacteria in blood and tissue
JPH0662844A (en) Hybridoma for producing monoclonal antibody reactive with endotoxin core
JPS60188847A (en) Method of diagnosing streptococcus a
JPH03277972A (en) Method of detecting listeria germ
US4666851A (en) Specific mycoplasma membrane antigen and antibody and their clinical applications
Påhlson et al. Curved rods related to Mobiluncus–phenotypes as defined by monoclonal antibodies
Svehag et al. Examination of virus-γM antibody complexes by electron microscopy I. Configuration of γM antibodies and mode of attachment to antigen
US4677080A (en) Rapid particle agglutination test for enterotoxigenic bacteria
JPS62151759A (en) Detection of antigen material
Reimann et al. AN INDIRECT HAEMAGGLUTINATION TEST FOR DEMONSTRATION OF GONOCOCCAL ANTIBODIES USING GONOCOCCAL PILI AS ANTIGEN: Methodology and Preliminary Results
CN111830263A (en) Establishment method of mycoplasma ovipneumoniae indirect hemagglutination detection method
CA1127536A (en) Identification of viral cell infections by antibody and bacteria
RU2611359C1 (en) Method and set for determination of cholera toxin production and differentiation of epidemiologically significant strains of cholera vibrios of classical and el tor biovars
Viljoen et al. Isolation of Cowdria ruminantium by cellular affinity chromatography and detection by an enzyme-linked immunosorbent assay
KR102149249B1 (en) Francisella tularensis diagnostic detection kit using rapid immunochromatography, its specific antibody and antibody-producing cell lines
RU2695525C1 (en) Method for immunoenzymometric detection of agent of pseudotuberculosis 1 serotype on basis of monoclonal antibodies to o-side chains of lipopolysaccharide
RU2737776C1 (en) Test kit for detecting cholera toxin in cultivation medium
US8642275B2 (en) Immunological tests for the presence of bacteria which make use of antibodies obtained using a specific method
JPS62500587A (en) Monoclonal antibodies and their uses
JP4217516B2 (en) Method for producing polyclonal antibody against Streptococcus mutans
RU2117700C1 (en) Strain of hybrid cultured cells of animal mus musculus l - a producer of monoclonal antibodies raised to pig vesicular disease virus, strain t-75
EP0463222A2 (en) Assay method for detecting viable listeria